Future research will be devoted to the identification of the subsets of target mRNAs that are bound by Id4 in breast cancer cells presenting wt-p53 (where Id4 is probably antitumorigenic) or mutant p53 (where Id4 is probably protumorigenic). Here, TP53 is linked to breast carcinoma.